首页> 美国卫生研究院文献>Endocrine Reviews >Progesterone Action in Endometrial Cancer Endometriosis Uterine Fibroids and Breast Cancer
【2h】

Progesterone Action in Endometrial Cancer Endometriosis Uterine Fibroids and Breast Cancer

机译:孕激素在子宫内膜癌子宫内膜异位症子宫肌瘤和乳腺癌中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Progesterone receptor (PR) mediates the actions of the ovarian steroid progesterone, which together with estradiol regulates gonadotropin secretion, prepares the endometrium for implantation, maintains pregnancy, and differentiates breast tissue. Separation of estrogen and progesterone actions in hormone-responsive tissues remains a challenge. Pathologies of the uterus and breast, including endometrial cancer, endometriosis, uterine fibroids, and breast cancer, are highly associated with estrogen, considered to be the mitogenic factor. Emerging evidence supports distinct roles of progesterone and its influence on the pathogenesis of these diseases. Progesterone antagonizes estrogen-driven growth in the endometrium, and insufficient progesterone action strikingly increases the risk of endometrial cancer. In endometriosis, eutopic and ectopic tissues do not respond sufficiently to progesterone and are considered to be progesterone-resistant, which contributes to proliferation and survival. In uterine fibroids, progesterone promotes growth by increasing proliferation, cellular hypertrophy, and deposition of extracellular matrix. In normal mammary tissue and breast cancer, progesterone is pro-proliferative and carcinogenic. A key difference between these tissues that could explain the diverse effects of progesterone is the paracrine interactions of PR-expressing stroma and epithelium. Normal endometrium is a mucosa containing large quantities of distinct stromal cells with abundant PR, which influences epithelial cell proliferation and differentiation and protects against carcinogenic transformation. In contrast, the primary target cells of progesterone in the breast and fibroids are the mammary epithelial cells and the leiomyoma cells, which lack specifically organized stromal components with significant PR expression. This review provides a unifying perspective for the diverse effects of progesterone across human tissues and diseases.
机译:孕酮受体(PR)介导卵巢甾体孕酮的作用,其与雌二醇一起调节促性腺激素的分泌,为植入子宫内膜做好准备,维持妊娠并分化乳房组织。激素反应性组织中雌激素和孕激素作用的分离仍然是一个挑战。子宫和乳房的病变,包括子宫内膜癌,子宫内膜异位,子宫肌瘤和乳腺癌,与雌激素高度相关,雌激素被认为是促有丝分裂因子。越来越多的证据支持孕酮的独特作用及其对这些疾病发病机理的影响。孕酮拮抗雌激素驱动的子宫内膜生长,而孕酮作用不足则显着增加子宫内膜癌的风险。在子宫内膜异位症中,异位和异位组织对孕酮的反应不足,被认为对孕激素具有抵抗力,这有助于增殖和存活。在子宫肌瘤中,孕酮通过增加增殖,细胞肥大和细胞外基质沉积来促进生长。在正常的乳腺组织和乳腺癌中,孕酮具有促增殖和致癌作用。这些组织之间的一个关键差异可以解释孕激素的多种作用,这是表达PR的基质与上皮的旁分泌相互作用。正常子宫内膜是一种粘膜,含有大量具有丰富PR的独特基质细胞,这会影响上皮细胞的增殖和分化并防止致癌性转化。相比之下,乳房和肌瘤中孕酮的主要靶细胞是乳腺上皮细胞和平滑肌瘤细胞,它们缺乏具有明显PR表达的特异组织基质成分。这篇综述提供了孕酮对人体组织和疾病的多种影响的统一观点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号